Determining the Lymphokine Activated Killer (LAK) Cytotoxicity Present in Patients Undergoing Interleukin-2 Therapy

NCT01068470 · clinicaltrials.gov ↗
TERMINATED
Status
11
Enrollment
OTHER
Sponsor class

Stopped PI left the institution

Conditions

Sponsor

Loma Linda University